Compare Arisyn Therapeutics vs BIND Therapeutics
Customers evaluate the quality of Arisyn Therapeutics's products using the following success metrics.
Overview
Arisyn Therapeutics is based in United States
Arisyn Therapeutics Inc. is a biotechnology company focused on the development of first in class inhibitors of infectious disease and cancer. Arisyn possesses a portfolio of small molecule compounds that will be developed to treat Human Immunodeficiency Virus-Type 1 (HIV-1), Human Immunodeficiency Virus-Type 2 (HIV-2), Human T-Lymphotropic Virus-Type 1 (HTLV-1), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Herpes Simplex Virus-Type 2 (HSV-2). Arisyn will perform all necessary studies required to develop these therapeutic agents through Phase 1 and Phase 2 human clinical trials.
BIND Therapeutics is 18 yrs old and is based in United States.
BIND Therapeutics, formerly BIND Biosciences, is a biopharmaceutical company leveraging its medicinal nanoengineering platform to design, engineer and manufacture targeted therapeutics. Medicinal nanoengineering complements medicinal chemistry to enable predictable, cost-effective, and rapid development of products with efficacy and safety profiles. Product opportunities include enabling or expediting the development of pipeline molecules as well as improving performance, expanding indications, or life cycle extension for mid- and late-stage products. BIND's initial product development efforts were in the areas of oncology, cardiovascular disorders, inflammatory disease, and RNAi therapeutics.
Demo Video
Leadership
Jeffrey Hrkach (Chief Technology Officer)
Investors
Frederick Innovative Technology Center
Pfizer, Flagship Pioneering
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Arisyn Therapeutics has not claimed their profile.
Work for Arisyn Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Arisyn Therapeutics?
Claim your profile now.
Information not available because BIND Therapeutics has not claimed their profile.
Work for BIND Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for BIND Therapeutics?
Claim your profile now.